grants

Grants Support Study of New Genes, New Drug Discovery Strategies for ALS

Twelve new grants totaling $3.6 million have been awarded in support of research studies that will explore the causes of, and potential treatments for, amyotrophic lateral sclerosis (ALS).

$13.6 Million in New MDA Grants Promote Understanding, Treatment of Neuromuscular Diseases

The Muscular Dystrophy Association has awarded 44 new grants totaling $13.6 million to advance the understanding and treatment of neuromuscular diseases. The new grants, most of which took effect Feb. 1, encompass a range of diseases covered by MDA’s research program, and they support innovative approaches to basic research and new drug development.

In addition to addressing 16 specific neuromuscular diseases under MDA’s umbrella, the grants also fund research into muscular dystrophy in general, and research into muscle physiology related to neuromuscular disease.

Grants for In-Home Care Available from Philanthropist with LGMD

A small nonprofit organization is offering limited grants for in-home care to people with physical disabilities. The next quality-of-life grant application deadline is November 1, 2012.

MDA Commits $10.7 Million to Neuromuscular Disease Research

The Muscular Dystrophy Association has awarded 33 new grants totaling $10,684,481 to fund research projects focused on uncovering the causes of, and developing therapies for, neuromuscular disease.

MDA's Board of Directors reviewed and approved the new grants based on recommendations from the Association's Scientific and Medical Advisory Committees, and the grants took effect Aug. 1.

Podcast: Howard Worman Discusses Research Related to Heart Disease in EDMD and LGMD1B

Recently, MDA grantee Howard Worman at Columbia University, and colleagues, published encouraging results about the effects of a drug called selumetinib on the hearts of mice with a genetic mutation that's found in a form of Emery-Dreifuss muscular dystrophy (EDMD). 

MDA Commits $12 Million to Neuromuscular Disease Research

The Muscular Dystrophy Association has awarded 38 new grants totaling more than $12 million to fund research projects focused on its continuing mission to uncover the causes of, and develop therapies for, the more than 40 neuromuscular diseases in its program.

MDA's Board of Directors reviewed and approved the new grants based on recommendations from the Association's Scientific and Medical Advisory Committees, and the grants took effect Feb. 1.

MDA Awards $2 Million in ALS Grants

Six new MDA grants totaling $2 million have been awarded to research projects seeking to uncover the basic mechanisms that drive ALS (amyotrophic lateral sclerosis), with an eye toward the development of future therapies. The grants took effect Feb. 1.

"It's exciting to see that recent scientific advances in ALS have spurred the funding of promising new areas of research," said MDA Vice President of Research Sanjay Bidichandani. "That's what happens when researchers let science lead the way."

MDA Funds Development of Utrophin 'Magnet' for DMD/BMD

 

MDA Awards More Than $2.5 Million in Grants to Stop ALS

MDA has awarded nine grants totaling more than $2.5 million to fund research projects focused on uncovering the causes of, and developing therapies for, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease).

The new grants went to investigators at labs in the United States and Canada.

The newly funded projects include research into:

MDA Awards $13.7 Million in Research Grants

The Muscular Dystrophy Association has awarded 40 research grants totaling $13.7 million to advance the understanding of disease processes and uncover new strategies for treatments and cures of muscular dystrophy and the more than 40 other diseases in the Association's program.

The new grants were recommended by MDA's Scientific and Medical Advisory Committees and approved by MDA's Board of Directors at its July 2011 meeting.

MDA in Your Community


Grants